45 related articles for article (PubMed ID: 28829501)
21. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
22. Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer.
Su M; Xiao Y; Tang J; Wu J; Ma J; Tian B; Zhou Y; Wang H; Yang D; Liao QJ; Wang W
J Cancer; 2018; 9(22):4156-4165. PubMed ID: 30519315
[TBL] [Abstract][Full Text] [Related]
23. Downregulated lncRNA HOXA11-AS Affects Trophoblast Cell Proliferation and Migration by Regulating RND3 and HOXA7 Expression in PE.
Xu Y; Wu D; Liu J; Huang S; Zuo Q; Xia X; Jiang Y; Wang S; Chen Y; Wang T; Sun L
Mol Ther Nucleic Acids; 2018 Sep; 12():195-206. PubMed ID: 30195759
[TBL] [Abstract][Full Text] [Related]
24.
Xue JY; Huang C; Wang W; Li HB; Sun M; Xie M
Onco Targets Ther; 2018; 11():4387-4393. PubMed ID: 30100744
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.
Yang Y; Yang H; Xu M; Zhang H; Sun M; Mu P; Dong T; Du S; Liu K
Hum Cell; 2018 Jul; 31(3):232-241. PubMed ID: 29679339
[TBL] [Abstract][Full Text] [Related]
26. The role of the long non-coding RNA HOXA11-AS in promoting proliferation and metastasis of malignant tumors.
Lu S; Jiang X; Su Z; Cui Z; Fu W; Tai S
Cell Biol Int; 2018 Dec; 42(12):1596-1601. PubMed ID: 30095197
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
28. Promotion of proliferation and metastasis of hepatocellular carcinoma by LncRNA00673 based on the targeted-regulation of notch signaling pathway.
Chen H; Liu JZ; Hu GJ; Shi LL; Lan T
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3412-3420. PubMed ID: 28829500
[TBL] [Abstract][Full Text] [Related]
29. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
30. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
31. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.
Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B
Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519
[TBL] [Abstract][Full Text] [Related]
32. Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1.
Yu J; Hong JF; Kang J; Liao LH; Li CD
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3402-3411. PubMed ID: 28829501
[TBL] [Abstract][Full Text] [Related]
33. HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.
Lu CW; Zhou DD; Xie T; Hao JL; Pant OP; Lu CB; Liu XF
Cancer Med; 2018 Aug; 7(8):3792-3799. PubMed ID: 29992790
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
